Accordingly, there is growing evidence for the role of IgE antibodies in anti-tumour immunosurveillance, including an inverse association between serum IgE levels and the risk of gynaecological cancers including ovarian cancer [128]. This evidence concerns the gene IGHE and neoplasm.